Live news related to TRANSGENE stock (FR0005175080): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Strasbourg-based biotechnology group Transgene has announced the pre-publication on medRxiv of a detailed analysis of Phase I trial data evaluating TG…
At the close of trading on Friday, December 12, 2025, Transgene's stock marked a significant increase of 7.17%, reaching 0.96 euros from 0.89 euros th…